Ring chromosome 10 syndrome

Ring chromosome 10 syndrome (also known as r(10) syndrome) is an extremely rare chromosomal disorder in which both ends of chromosome 10 are deleted and the remaining segments fuse to form a ring-shaped structure. This rearrangement results in the loss of genetic material from the short arm (10p) and long arm (10q) of chromosome 10, leading to a variable clinical presentation depending on the extent of the deleted segments. The condition typically arises as a de novo event during early embryonic development. The syndrome affects multiple body systems. Key clinical features include intellectual disability of variable severity, growth retardation (both prenatal and postnatal), microcephaly, and distinctive craniofacial features such as a broad or flat nasal bridge, hypertelorism, low-set or malformed ears, and micrognathia. Ocular abnormalities, cardiac defects, and skeletal anomalies have also been reported in some patients. Behavioral difficulties and speech delay are commonly observed. Ring chromosome instability may lead to mosaic cell lines with monosomy or other secondary rearrangements, contributing to phenotypic variability among affected individuals. There is no cure or specific targeted therapy for ring chromosome 10 syndrome. Management is supportive and symptomatic, involving a multidisciplinary team that may include pediatricians, cardiologists, ophthalmologists, orthopedic specialists, speech therapists, and developmental specialists. Early intervention programs, special education services, and physical and occupational therapy can help optimize developmental outcomes. Regular monitoring for associated complications, particularly cardiac and skeletal anomalies, is recommended. Genetic counseling is advised for affected families to discuss recurrence risk and prognosis.

Common questions about Ring chromosome 10 syndrome